Mr. Gambler asked, "Now, here's my question for

New Post Public Reply Private Reply Replies (1) Message Board
SporadicE HHIGambler #137679
849

Mr. Gambler asked,
"Now, here's my question for you: can you give me examples of how the executive officers have met or exceeded their performance during the last year that would warrant an increase in their compensation?"

I like the way you think, Mr. Gambler. Your question is an excellent one and strikes right at the opaqueness of the current management.
We do not have any way to judge the performance of the executive officers. I have not seen any of their metrics to evaluate performance so that is why I came up with the 2 metrics that seem important to me-1) keep the company open 2) Get the FDA hold lifted
So this management is batting 50% so far. On the face of it- not so good. You feel that 2 years is enough to get the hold lifted and if they fail then their compensation should reflect that failure. I would usually agree. But if that happens then CYDY can kiss off attracting any real talent that the FDA might respect. We need an interim CEO like Ed Kaye, who the FDA respects, who has been in this kind of a situation before with SRPT and left shortly after the FDA approved their drug.. I just don't think a company like CYDY can attract a CEO like Ed, who is known in the business, without some sort of a enhanced pay for performance clause in the contract offer. That is way wrong but that is the situation CYDY is in.
At this point I don't think it takes a lot of talent to listen closely to what the FDA is asking for and then provide it promptly. If the FDA wants a specific way to run a specific trial, and if CYDY doesn't have the talent to provide the details, then they should contract out that job.
We really don't know what the FDA is now requiring of CYDY to lift the hold.
You've made it clear that 2 years is enough time. I'd agree with you on that usually but I think CYDY got way deep on the FDA's bad side for a number of reasons. It is going to take longer to climb back out of that hole.
I'll give them 3 years to get it done. Our reward and health care's reward will be significant but we can only wait and watch and grasp at any morsels of info that get passed our way.
It ain't right- but that is how it is trying to break into big pharma.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kansas City Life Welcomes Kellie Needham to Board

Updated Category News Views 48

A New Era in Kansas City Life's Leadership This ain't your run-of-the-mill board appointment, folks. Kansas City Life Insurance Company has just handed the reins to Kellie S. Needham, who steps in to fill her mother's recently vacated board seat. Imagine that—a family legacy stretching back to the early 1900s when J.B. Reynolds first laid the foundation. Legacy Unbroken...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 0

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading
Systemair Shakes Things Up: Closing Netherlands Facility

Updated Category News Views 81

Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 0

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading
Barco Brings HDR Cinema Home with Kinepolis Kortrijk

Updated Category News Views 230

A New Chapter in Cinema Projection Ah, Belgium, the land of waffles and apparently, cutting-edge cinema tech. That's right, Barco is bringing their HDR by Barco system to its own backyard in Kortrijk, teaming up with Kinepolis to shake things up. It's not just any expansion—it's a homecoming of sorts. The company's laser cinema magic has already made face time in the...

Continue Reading
Food Emulsifiers Surge: Market to Hit $5.60B by 2031

Updated Category News Views 52

Forecasting Growth in Food Emulsifiers Picture this: the food emulsifiers market is steaming ahead, anticipating a thunderous boom from $4.43 billion in 2026 to a whopping $5.60 billion by 2031. According to recent estimates, that's a steady clip at a CAGR of 4.8%. If you're thinking that's just more industry chatter, let's peel back the layers and see what makes this...

Continue Reading
Landstar Faces Legal Storm Post Earnings Miss

Updated Category News Views 17

Landstar's Earnings Misstep Sends Shockwaves Alright, let's talk about this snafu at Landstar (NASDAQ: LSTR). They were supposed to deliver an earnings sheet that's all roses, but instead, we got a couple of thorns. Analysts were expecting them to strike gold with EPS numbers between $1.62 to $1.67. What we got? A measly $1.42. Not exactly the shiny haul we were led to...

Continue Reading
NeuroSense's Phase 3 Strategies for PrimeC Unveiled

Updated Category News Views 79

How NeuroSense Is Poised to Tackle ALS Treatment Picture this: a room full of people holding their breath, hoping that NeuroSense can deliver the breakthrough they’ve been inching toward. It’s the kind of moment that gives you goosebumps if you've been sloggin' through the biotech trenches. NeuroSense’s pitch at NEALS is more than just a dog and pony show—it's a...

Continue Reading
YSS Faces Legal Heat Over Misleading Investor Claims

Updated Category News Views 27

YSS Investors Navigate Legal Waters as Class Action Looms Taking a slug of coffee this morning and diving right into it—York Space Systems has found itself in hot water. They went public earlier this year with what was supposed to be a shining opportunity under the NYSE:YSS ticker, but it turns out that not everything in their IPO shined—and now SBS Law is stepping up...

Continue Reading
Why Haunted Attractions Keep Us Coming Back for Fear

Updated Category News Views 90

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Continue Reading

Top 5 Most Recently Viewed Articles

MetroCity Bankshares and First IC Corporation Set Merger Date

Updated Category News Views 186

MetroCity Bankshares and First IC Corporation Set Merger Date MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, is excited to share that it has successfully received all necessary regulatory approvals to finalize its merger with First IC Corporation. Both companies are looking forward to completing this significant transaction, which they...

Continue Reading
XOMA Corporation Achieves Milestone with Stock Surge to $30.7

Updated Category News Views 158

XOMA Corporation Achieves a 52-Week High XOMA Corporation has recently captured the attention of the market as its stock reached an impressive 52-week high of $30.7. This remarkable achievement signals a transformative growth period for the biotech company, witnessing a robust stock price increase of 68.72% over the last year. Investors have responded positively,...

Continue Reading
JAGGAER's ESG Impact Report: Strides in Sustainability and Engagement

Updated Category News Views 164

JAGGAER’s Commitment to Environmental and Social Governance JAGGAER, a leader in enterprise procurement, has released its third Environmental, Social, and Corporate Governance (ESG) Impact Report for the year. The company helps organizations streamline complex procurement and supplier collaboration, with ESG woven into the software that powers those processes. By...

Continue Reading
PEAK BlueDEF® Innovations Enhance Diesel Exhaust Fluid Quality

Updated Category News Views 79

Innovative Steps by Old World Industries to Boost PEAK BlueDEF® Old World Industries, a renowned name in the automotive industry, has embarked on a significant journey to elevate the quality of its PEAK® BlueDEF® product line. Known for its commitment to excellence, the company has announced an investment in a new triple-filtration process aimed at enhancing the purity...

Continue Reading
Celebrate in Style with Ketel One's Lemon Drop Martini

Updated Category News Views 186

Embrace Effortless Celebrations with The Cocktail Collection This holiday season, The Cocktail Collection elevates your hosting game with its exquisite new offering. The Ketel One Lemon Drop Martini stands out as a favorite, representing a fusion of flavor and fun, perfect for any festive gathering. With this delightful cocktail on hand, you can make any occasion feel...

Continue Reading